# McKesson vs Medtronic: valuation, size and margins compared

URL: https://funkfolio.com/compare/mck-vs-mdt

> McKesson ($126B, P/E 28.5) and Medtronic ($130.9B, P/E 25.3) compared: size, valuation, margins, debt, cash and price change.

---

## McKesson vs Medtronic

McKesson (MCK), health care, and Medtronic (MDT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Medtronic is worth $130.9B on the stock market and McKesson $126B: Medtronic is valued at 4% more. McKesson trades at 28.5 times earnings and Medtronic at 25.3; operating margins in their latest fiscal years were 1.54% and 17.8%. Over the past year McKesson's share price has moved +28.4% and Medtronic's +2.06%.

### Key facts

- **McKesson market value:** $126B
- **Medtronic market value:** $130.9B
- **McKesson P/E:** 28.5
- **Medtronic P/E:** 25.3
- **McKesson revenue:** $403.4B FY to 2026-03-31
- **Medtronic revenue:** $36.4B FY to 2026-04-24
- **Superinvestors holding both:** 4

Market values as of 18 Nov 2026, 04:52 UTC.

McKesson vs Medtronic: every measure side by side

| Measure | McKesson | Medtronic |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | Ireland |
| Fiscal year ends | 2026-03-31 | 2026-04-24 |
| Size |  |  |
| Market cap | $126B lower | $130.9B higher |
| Revenue | $403.4B higher | $36.4B lower |
| Earnings | $4.8B lower | $4.8B higher |
| Employees | 41,600 lower | 95,000 higher |
| Total assets | $82.3B lower | $93B higher |
| Valuation |  |  |
| P/E | 28.5 higher | 25.3 lower |
| P/S | 0.3 lower | 3.6 higher |
| P/B | — | — |
| Dividend yield | 0.31% | — |
| Profitability |  |  |
| Operating margin | 1.54% lower | 17.8% higher |
| Balance sheet |  |  |
| Net assets | -$2.2B lower | $49.5B higher |
| Total liabilities | $83.2B higher | $43B lower |
| Total debt | $6.5B lower | $28B higher |
| Cash on hand | $4B higher | $1.9B lower |
| Price change |  |  |
| Today | -1.21% lower | -0.54% higher |
| 1 year | +28.4% higher | +2.06% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: McKesson 127.6, Medtronic 106.3.

- McKesson (MCK)
- Medtronic (MDT)

McKesson and Medtronic share prices over one year, rebased to 100: McKesson ends at 127.6, Medtronic at 106.3.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | MCK | MDT |
| --- | --- | --- |
| Nov 28, 2025 | 103.0 | 109.4 |
| Dec 31, 2025 | 95.9 | 99.8 |
| Jan 30, 2026 | 97.2 | 106.9 |
| Feb 27, 2026 | 115.5 | 101.4 |
| Mar 31, 2026 | 101.2 | 90.0 |
| Apr 30, 2026 | 95.3 | 84.1 |
| May 29, 2026 | 86.8 | 76.7 |
| Jun 30, 2026 | 88.4 | 81.3 |
| Jul 31, 2026 | 100.1 | 88.7 |
| Aug 31, 2026 | 103.5 | 94.2 |
| Sep 30, 2026 | 99.8 | 89.6 |
| Oct 30, 2026 | 116.3 | 100.3 |
| Nov 17, 2026 | 127.6 | 106.3 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (4)

- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.2% / 0.2%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2% / 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2% / 0.2%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) &lt;0.1% / 1.2%

#### McKesson only (9)

- [Ron Muhlenkamp (founder)](https://funkfolio.com/gurus/ron-muhlenkamp) 5.7%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.8%
- [Frank Sands](https://funkfolio.com/gurus/frank-sands) 0.6%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.4%
- [Stephen Mandel](https://funkfolio.com/gurus/stephen-mandel) 0.3%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.2%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.1%
- [Temasek](https://funkfolio.com/gurus/temasek) &lt;0.1%

#### Medtronic only (6)

- [Matthew McLennan](https://funkfolio.com/gurus/first-eagle) 1.9%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 1.4%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.8%
- [Mark Boyar](https://funkfolio.com/gurus/mark-boyar) 0.4%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 0.3%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) 0.3%

Percentages are each holding's share of that investor's reported portfolio (under "Both": McKesson / Medtronic). [Who owns MCK](https://funkfolio.com/stock/MCK/superinvestors) · [Who owns MDT](https://funkfolio.com/stock/MDT/superinvestors)

### More on McKesson

- [McKesson (MCK) stock page](https://funkfolio.com/stock/MCK)
- [McKesson market cap](https://funkfolio.com/stock/MCK/market-cap)
- [McKesson revenue](https://funkfolio.com/stock/MCK/revenue)
- [McKesson P/E ratio](https://funkfolio.com/stock/MCK/pe-ratio)
- [McKesson operating margin](https://funkfolio.com/stock/MCK/operating-margin)
- [McKesson total debt](https://funkfolio.com/stock/MCK/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Medtronic

- [Medtronic (MDT) stock page](https://funkfolio.com/stock/MDT)
- [Medtronic market cap](https://funkfolio.com/stock/MDT/market-cap)
- [Medtronic revenue](https://funkfolio.com/stock/MDT/revenue)
- [Medtronic P/E ratio](https://funkfolio.com/stock/MDT/pe-ratio)
- [Medtronic operating margin](https://funkfolio.com/stock/MDT/operating-margin)
- [Medtronic total debt](https://funkfolio.com/stock/MDT/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### McKesson against its closest peers

- [McKesson vs Stryker](https://funkfolio.com/compare/mck-vs-syk)
- [McKesson vs Bristol-Myers Squibb](https://funkfolio.com/compare/bmy-vs-mck)
- [McKesson vs Sanofi](https://funkfolio.com/compare/mck-vs-sny)

#### Medtronic against its closest peers

- [Medtronic vs Bristol-Myers Squibb](https://funkfolio.com/compare/bmy-vs-mdt)
- [Medtronic vs Vertex Pharmaceuticals](https://funkfolio.com/compare/mdt-vs-vrtx)
- [Medtronic vs Stryker](https://funkfolio.com/compare/mdt-vs-syk)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, McKesson or Medtronic?**

By market value, Medtronic is the larger: $130.9B against $126B for McKesson. By revenue in its latest fiscal year, McKesson is the larger: $403.4B against $36.4B for Medtronic.

**Which has the higher P/E ratio?**

McKesson: 28.5, against 25.3 for Medtronic. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Medtronic: 17.8%, against 1.54% for McKesson. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

Medtronic: $28B, against $6.5B for McKesson. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both McKesson and Medtronic?**

In their latest 13F filings, David Shaw (founder), Ray Dalio (founder), Ken Griffin and Howard Gleicher hold both.

### Cite this page

Funkfolio, “McKesson vs Medtronic”, data as of 18 November 2026. https://funkfolio.com/compare/mck-vs-mdt

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
